Abstract Body

Background: We have previously shown soluble biomarkers of inflammation, including an IL-6/D-dimer composite score, independently predict non-AIDS related morbidity and mortality. We explored associations between select biomarkers and cellular immunophenotypes to identify potential mechanisms of excess inflammation among HIV-infected adults. Methodology: Baseline plasma specimens from SUN Study participants were analyzed for levels of IL-6, hsCRP, sCD14, sCD163, and D-dimer. We performed immunophenotyping for markers of T cell activation and maturation (HLA-DR, CD38, CX3CR1, CD28, CD57) and monocyte activation and migration (CCR2, CD14, CD16, tissue factor [TF], CX3CR1, CCR5). We evaluated associations between cellular phenotypes and soluble markers by Spearman rank correlation. Linear regression was used to estimate the percent change in plasma biomarker level for each 5 unit difference in cellular phenotype, after adjustment for: age, gender, race, smoking, diabetes, treatment for hypertension or hyperlipidemia, hepatitis, CD4 cell count, and HIV RNA <400 copies/mL. Due to multiple comparisons, we defined significance as p-value ≤0.01. Results: Participants’ (n=670) median age was 41 years and CD4 count 471 cells/μL; 76% were male, 44% smokers, 88% on ART, and 72% had HIV RNA <400 copies/mL. Correlations of biomarkers with select cellular phenotypes are shown (Table). In fully adjusted models, a 5 unit greater frequency of CD14++CD16+ monocytes was associated with 11.4% higher IL-6 (p<0.001), 27.5% higher D-dimer (p<0.001), and 10.9% higher hsCRP (p=0.004); a corresponding difference of monocytes expressing CCR2 was associated with 6.9% lower D-dimer (p=0.003) and CCR5 with 1.4% higher sCD163 (p<0.001). Of T-cell subsets, greater frequencies of CD4+HLADR+CD38+ T-cells were independently associated with higher sCD163 (5.1%, p<0.001) and CD8+CD28+ T-cells with lower sCD163 (3.0%, p=0.001) and D-dimer (1.2%, p=0.001). Finally, an IL-6/D-dimer clinical risk score was positively associated with CD14++CD16+ monocytes (p<0.001) and inversely with CD8+CD28+ T-cells (p=0.009) in adjusted models. Conclusions: Plasma biomarkers that strongly predict clinical risk for non-AIDS morbidity were consistently and strongly associated with monocyte activation phenotypes and modestly with T-cell maturation, but not CD8+ T-cell activation, phenotypes. These findings may help direct treatment strategies to control persistent inflammation in chronic HIV disease.